Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:22:46 EDT Mon 14 Jul 2025
Enter Symbol
or Name
USA
CA



Q:ENGN - ENGENE HOLDINGS INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ENGN - Q0.23.25·3.700.13.34+0.030.920.6551953.33  3.44  3.24511.00  2.6616:04:16Jul 0815 min RT 2¢

Recent Trades - Last 10 of 195
Time ETExPriceChangeVolume
16:04:16Q3.340.031
16:04:10Q3.340.031
16:04:09Q3.40920.09925
16:00:01Q3.340.03140
16:00:01Q3.340.03898
16:00:01Q3.340.0371
16:00:01Q3.340.03313
16:00:01Q3.340.032
16:00:00Q3.30-0.0138
16:00:00Q3.30-0.0134

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-08 08:00U:ENGNNews ReleaseenGene Announces Board and Leadership Appointments to Support Commercial Readiness
2025-06-25 08:00U:ENGNNews ReleaseFDA Grants RMAT Designation for enGene's Detalimogene, Enabling Potential for Expedited Review in High-Risk, Non-Muscle Invasive Bladder Cancer
2025-06-17 08:00U:ENGNNews ReleaseenGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2025-06-12 08:00U:ENGNNews ReleaseenGene Reports Second Quarter 2025 Financial Results and Provides Business Update
2025-06-04 08:30U:ENGNNews ReleaseenGene Announces the Resignation of its Chief Medical Officer
2025-05-29 08:00U:ENGNNews ReleaseenGene to Present at the Jefferies Global Healthcare Conference
2025-05-28 07:30U:ENGNNews ReleaseenGene Names Amy Pott as Chief Global Commercialization Officer
2025-04-28 08:00U:ENGNNews ReleaseenGene to Participate in Upcoming Investor Conferences
2025-04-04 08:00U:ENGNNews ReleaseenGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2025-04-01 08:00U:ENGNNews ReleaseenGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum
2025-03-10 16:05U:ENGNNews ReleaseenGene Reports First Quarter 2025 Financial Results and Provides Business Update
2025-03-04 08:00U:ENGNNews ReleaseenGene to Participate in the Leerink Partners Global Healthcare Conference
2025-02-04 08:00U:ENGNNews ReleaseenGene to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
2025-01-31 16:05U:ENGNNews ReleaseenGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2025-01-30 08:00U:ENGNNews ReleaseenGene to Present Three Posters at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) Highlighting the Ongoing Clinical Development of Detalimogene Voraplasmid for the Treatment of Non-Muscle Invasive Bladder Cancer (NMIBC)
2024-12-30 16:05U:ENGNNews ReleaseenGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2024-12-19 16:05U:ENGNNews ReleaseenGene Reports Full Year 2024 Financial Results and Provides a Business Update
2024-11-25 08:00U:ENGNNews ReleaseenGene to Participate in Upcoming Investor Conferences
2024-11-05 08:00U:ENGNNews ReleaseenGene to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
2024-10-25 08:00U:ENGNNews ReleaseenGene Announces $60 Million Private Placement Financing